Skip to main content
Clinical Trials/NCT05962996
NCT05962996
Recruiting
Not Applicable

Evaluation of Pain Levels by Quantitative Pupillometry During the Placement of Deep Venous Catheters in Sedated Patients in Intensive Care Unit

Centre Hospitalier Régional Universitaire de Tours2 sites in 1 country90 target enrollmentSeptember 1, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Critical Illness
Sponsor
Centre Hospitalier Régional Universitaire de Tours
Enrollment
90
Locations
2
Primary Endpoint
Change in variation of pupillary diameter by quantitative pupillometry
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

Pain is common in intensive care and gives rise to multiple consequences that can impact the future of patients. The placement of deep venous catheters are painful gestures of common practice in intensive care. However, some patients are ventilated and sedated and their level of pain is difficult to judge. Quantitative pupillometry seems to be a reliable tool for assessing pain in these patients unable to communicate. The method is already common practice in the operating room for this indication and recent studies increasingly validate its use in intensive care.

The aim of the study is to validate the different levels of pain that can be assessed by pupillometry within this population during catheterization and to identify any non-responding subgroups (in order to conduct future clinical trials evaluating pain therapies).

Detailed Description

Three groups of patients will be studied : with aminergic drugs / with curare / without aminergic drugs nor curare. The measurement of pain levels by quantitative pupillometry (NPi®-200 pupillometer, NeurOptics® USA) will be made in intubated, sedated patients, unable to communicate on their level of pain during the placement of a deep venous catheter. Pain will be evaluated before starting the placement of the catheter, at puncture(s), at dilation(s), and during the suture of the catheter. Simultaneously, RASS and BPS scores as well as the patient's vital parameters and the cumulative doses of sedation-analgesia, curare and aminergic drugs will be collected.

Registry
clinicaltrials.gov
Start Date
September 1, 2023
End Date
August 1, 2024
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Centre Hospitalier Régional Universitaire de Tours
Responsible Party
Principal Investigator
Principal Investigator

Ambre Sauvage

Principal Investigator

Centre Hospitalier Régional Universitaire de Tours

Eligibility Criteria

Inclusion Criteria

  • Patient aged over 18 hospitalized in Intensive Care Unit
  • Requiring the placement of a deep venous catheter (central venous catheter or dialysis catheter)
  • Sedated, intubated, unable to communicate about pain
  • No opposition to participation in the study

Exclusion Criteria

  • Any ophthalmological pathology (lesion of the orbital cavity, edematous soft tissue or with an open lesion)
  • Any intracranial pathology (stroke, subarachnoid hemorrhage, tumour, etc.)
  • Patient post-cardio-respiratory arrest within the first 48 hours
  • Medicines interfering with the pupillary reflex: clonidine dexmedetomidine, droperidol, metoclopramide, nitric oxide, scopolamine, atropine
  • Patient protected within the law
  • Previous participation in the study

Outcomes

Primary Outcomes

Change in variation of pupillary diameter by quantitative pupillometry

Time Frame: During the insertion of the deep venous catheter : before starting the placement of the catheter, at puncture(s), at dilation(s), and during the suture of the catheter (through study completion : an average of 20 minutes)

Pupillary variation (%) = \[maximum pupil diameter (mm) - minimum pupil diameter (mm)\] / maximum pupil diameter (mm)\]

Secondary Outcomes

  • Changes in pupil constriction by quantitative pupillometry(During the insertion of the deep venous catheter : before starting the placement of the catheter, at puncture(s), at dilation(s), and during the suture of the catheter (through study completion : an average of 20 minutes))
  • Changes in pupillary reflex latency by quantitative pupillometry(During the insertion of the deep venous catheter : before starting the placement of the catheter, at puncture(s), at dilation(s), and during the suture of the catheter (through study completion : an average of 20 minutes))
  • Changes in pupil dilatation by quantitative pupillometry(During the insertion of the deep venous catheter : before starting the placement of the catheter, at puncture(s), at dilation(s), and during the suture of the catheter (through study completion : an average of 20 minutes))
  • Changes in NPi by quantitative pupillometry(During the insertion of the deep venous catheter : before starting the placement of the catheter, at puncture(s), at dilation(s), and during the suture of the catheter (through study completion : an average of 20 minutes))
  • Changes in BPS scores(During the insertion of the deep venous catheter : before starting the placement of the catheter, at puncture(s), at dilation(s), and during the suture of the catheter (through study completion : an average of 20 minutes))
  • Changes in respiratory rate(During the insertion of the deep venous catheter : before starting the placement of the catheter, at puncture(s), at dilation(s), and during the suture of the catheter (through study completion : an average of 20 minutes))
  • Changes in heart rate(During the insertion of the deep venous catheter : before starting the placement of the catheter, at puncture(s), at dilation(s), and during the suture of the catheter (through study completion : an average of 20 minutes))
  • Changes in blood pressure(During the insertion of the deep venous catheter : before starting the placement of the catheter, at puncture(s), at dilation(s), and during the suture of the catheter (through study completion : an average of 20 minutes))

Study Sites (2)

Loading locations...

Similar Trials